ALRN - Aileron Therapeutics Inc. (ALRN) CEO Manuel Aivado on Q3 2019 Results - Earnings Call Transcript
Aileron Therapeutics, Inc. (ALRN)
Q3 2019 Earnings Conference Call
November 07, 2019 08:30 AM ET
Company Participants
Rick Wanstall - Head of Finances
Manuel Aivado - President & Chief Executive Officer
Vojislav Vukovic - Chief Medical Officer
Allen Annis - Head of Research
Conference Call Participants
Rob Andrew - William Blair
Justin Zelin - Canaccord
Jacques Villefranc - LifeSci Capital
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Aileron Therapeutics Third Quarter 2019 Financial and Operational update. At this time, all participants are in a listen only mode. There